• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Interferon alfa therapy in CALR-mutated essential thrombocythemia.

作者信息

Cassinat Bruno, Verger Emmanuelle, Kiladjian Jean-Jacques

机构信息

Hôpital Saint-Louis, Paris, France.

出版信息

N Engl J Med. 2014 Jul 10;371(2):188-9. doi: 10.1056/NEJMc1401255.

DOI:10.1056/NEJMc1401255
PMID:25006741
Abstract
摘要

相似文献

1
Interferon alfa therapy in CALR-mutated essential thrombocythemia.干扰素α治疗CALR突变型原发性血小板增多症。
N Engl J Med. 2014 Jul 10;371(2):188-9. doi: 10.1056/NEJMc1401255.
2
Essential thrombocythaemia.原发性血小板增多症
Hematology. 2015 Mar;20(2):119-20. doi: 10.1179/1024533215Z.000000000349.
3
CALR versus JAK2 mutated essential thrombocythaemia - a report on 141 patients.CALR与JAK2突变的原发性血小板增多症——141例患者的报告
Br J Haematol. 2015 Jan;168(1):151-3. doi: 10.1111/bjh.13076. Epub 2014 Aug 8.
4
Somatic mutations of calreticulin in myeloproliferative neoplasms.髓系增殖性肿瘤中的钙网织蛋白体细胞突变。
N Engl J Med. 2013 Dec 19;369(25):2379-90. doi: 10.1056/NEJMoa1311347. Epub 2013 Dec 10.
5
Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis.通过高分辨率熔解分析在JAK2 V617F突变的原发性血小板增多症中检测到频繁的CALR外显子9改变。
Blood Cancer J. 2015 Mar 20;5(3):e295. doi: 10.1038/bcj.2015.21.
6
A novel somatic CALR mutation in essential thrombocythemia and effective response to interferon-alfa-2b therapy.
Blood Cells Mol Dis. 2018 Nov;73:22-24. doi: 10.1016/j.bcmd.2018.08.004. Epub 2018 Aug 30.
7
Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment.干扰素α治疗期间骨髓增殖性肿瘤中CALR突变等位基因负担的差异动态变化
PLoS One. 2016 Oct 20;11(10):e0165336. doi: 10.1371/journal.pone.0165336. eCollection 2016.
8
Essential Thrombocythemia Associated With Germline JAK2 G571S Variant and Somatic CALR Type 1 Mutation.与种系JAK2 G571S变异和体细胞CALR 1型突变相关的原发性血小板增多症。
Clin Lymphoma Myeloma Leuk. 2016 May;16(5):e55-7. doi: 10.1016/j.clml.2016.02.039. Epub 2016 Feb 27.
9
Constitutional genetic association with CALR mutations?
Leukemia. 2015 Dec;29(12):2410-1. doi: 10.1038/leu.2015.186. Epub 2015 Jul 22.
10
Two faces of ET: CALR and JAK2.ET 的两面：CALR 和 JAK2。
Blood. 2014 Mar 6;123(10):1438-40. doi: 10.1182/blood-2014-01-547596.

引用本文的文献

1
Effects of Calreticulin Mutations on HLA Class I Expression in Myeloproliferative Neoplasms.钙网蛋白突变对骨髓增殖性肿瘤中HLA I类分子表达的影响
bioRxiv. 2025 Jun 27:2025.06.24.661416. doi: 10.1101/2025.06.24.661416.
2
Pegylated interferon: the who, why, and how.聚乙二醇化干扰素：适用人群、作用原理及使用方法
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):535-540. doi: 10.1182/hematology.2024000577.
3
Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape.
骨髓增殖性肿瘤中的克隆结构演变：从驱动突变到复杂的异质性突变和表型景观。
Leukemia. 2023 May;37(5):957-963. doi: 10.1038/s41375-023-01886-0. Epub 2023 Mar 31.
4
Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms.推断 IFNα 诱导骨髓增殖性肿瘤中突变造血干细胞和祖细胞的动力学。
Blood. 2021 Dec 2;138(22):2231-2243. doi: 10.1182/blood.2021010986.
5
Clinical outcomes of interferon therapy for polycythemia vera and essential thrombocythemia: a systematic review and meta-analysis.干扰素治疗真性红细胞增多症和原发性血小板增多症的临床结局：系统评价和荟萃分析。
Int J Hematol. 2021 Sep;114(3):342-354. doi: 10.1007/s12185-021-03171-1. Epub 2021 Jun 6.
6
Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms.克隆性造血与骨髓增殖性肿瘤的突变
Cancers (Basel). 2020 Jul 28;12(8):2100. doi: 10.3390/cancers12082100.
7
Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature.干扰素α在骨髓增殖性肿瘤治疗中的应用：文献综述与展望
Cancers (Basel). 2020 Jul 18;12(7):1954. doi: 10.3390/cancers12071954.
8
Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms.费城染色体阴性慢性骨髓增殖性肿瘤的癌症免疫疗法
Cancers (Basel). 2020 Jul 2;12(7):1763. doi: 10.3390/cancers12071763.
9
Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative Neoplasms.α干扰素治疗可增加骨髓增殖性肿瘤患者的促血栓形成生物标志物。
Cancers (Basel). 2020 Apr 17;12(4):992. doi: 10.3390/cancers12040992.
10
Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018.骨髓增殖性肿瘤相关内脏静脉血栓形成：2018 年治疗算法。
Blood Cancer J. 2018 Jun 26;8(7):64. doi: 10.1038/s41408-018-0100-9.